Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.23 USD
Change Today 0.0001 / 0.04%
Volume 12.0K
AOLS On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John L. McManus

Chief Executive Officer and President,Aeolus Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Mr. John L. McManus has been the Chief Executive Officer of Aeolus Pharmaceuticals Inc., since March 2007 and as its President June 20, 2005. Mr. McManus is the Founder of McManus Financial Consultants, Inc. and has been its President since 1989. He served as Principal Accounting Officer and Treasurer of Aeolus Pharmaceuticals Inc. and also served as its Secretary. He served as the Chief Financial Officer of Aeolus Pharmaceuticals from January 15, 2010 to February 2011. ...

Read Full Background

Corporate Headquarters*

26361 Crown Valley Parkway
Mission Viejo, California 92691

United States

Phone: 949-481-9825
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree 1986
University of Southern California
University of Southern California

Other Affiliations*

Annual Compensation*

Total Annual Compensation$433,908

Stock Options*

Exercisable Options6,495,000
Unexercisable Options125,000
Total Number of Options6,620,000

Total Compensation*

Total Annual Cash Compensation$433,908
Total Short Term Compensation$433,908
Total Calculated Compensation$748,663
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AOLS:US $0.23 USD 0.0001


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AEOLUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at